EE92 Budget Impact Analysis of Obecabtagene Autoleucel for Adults With Relapsed/Refractory B-cell ALL From a US Payer Perspective
Abstract
Authors
Annika Bjerke Spencer Notinger Jeff Lee dilip Patel David Bertwistle David Huggar